Cancer and the Small Interfering RNA Market: Silencing Tumour Drivers

добавлена новая статья Health

2026-10-27 06:13:23 - Перевод -

Cancer is the largest application segment of the small interfering RNA market, and for good reason. Many cancers are driven by overexpressed genes or dysregulated pathways that siRNA can silence with high specificity. This capability offers a precision approach that complements traditional chemotherapy and emerging immunotherapies. siRNA cancer therapeutics target oncogenes, growth factors, and...

0 Комментарии 0 Поделились 127 Просмотры 0 предпросмотр